ShanGeng Weng (Shangeng Weng)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Locally Advanced

Chemotherapy Induced

Cell Cycle Arrest

Top Venues

Cell death & disease

Obesity surgery

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Genes and immunity

This page only lists publications with an associated author ORCID identifier.

Publications

Hailing Guo, Qingzhu Ding, Yue Huang, Zhenyun Guo, Fadian Ding, Han Zhang, Zhou Zheng, Xiang Zhang, ShanGeng Weng
Multi-omics Analysis Reveals the Crucial Mediators of DJB in the Treatment of Type 2 Diabetes. Obesity surgery (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (7) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, ShanGeng Weng
METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation. Cell death & disease 14 (3) (2023)
Fadian Ding, Yunfeng Lin, Guozhong Liu, Yuxin Liu, Feng Gao, Qicai Liu, Zhi-Bo Zhang, ShanGeng Weng
Immune disguise: the mechanisms of Neu5Gc inducing autoimmune and transplant rejection. Genes and immunity 23 (6) (2022)
YiPing Chen, ShanGeng Weng
Reappraisal of the T Category for Solitary Intrahepatic Cholangiocarcinoma by Tumor Size in 611 Early-Stage (T1-2N0M0) Patients After Hepatectomy: a Surveillance, Epidemiology, and End Results (SEER) Analysis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 25 (8) (2020)